ArticleHaematologica2012

Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia.

Michaela Liedtke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.